Angles-Cano E - Search Results

1

Evidence for several independent genetic variants affecting lipoprotein (a) cholesterol levels.

Lu W, Cheng YC, Chen K, Wang H, Gerhard GS, Still CD, Chu X, Yang R, Parihar A, O'Connell JR, Pollin TI, Angles-Cano E, Quon MJ, Mitchell BD, Shuldiner AR, Fu M. Lu W, et al. Hum Mol Genet. 2015 Apr 15;24(8):2390-400. doi: 10.1093/hmg/ddu731. Epub 2015 Jan 9. Hum Mol Genet. 2015. PMID: 25575512 Free PMC article.

2

Lipoprotein(a) concentration, genetic variants, apo(a) isoform size, and cellular cholesterol efflux in patients with elevated Lp(a) and coronary heart disease submitted or not to lipoprotein apheresis: An Italian case-control multicenter study on Lp(a).

Stefanutti C, Pisciotta L, Favari E, Di Giacomo S, Vacondio F, Zenti MG, Morozzi C, Berretti D, Mesce D, Vitale M, Pasta A, Ronca A, Garuti A, Manfredini M, Anglés-Cano E, Marcovina SM, Watts GF; Multidisciplinary International Group for Hemapheresis TherapY and MEtabolic DIsorders Control – ‘MIGHTY MEDIC.ORG’. Stefanutti C, et al. J Clin Lipidol. 2020 Jul-Aug;14(4):487-497.e1. doi: 10.1016/j.jacl.2020.05.002. Epub 2020 May 19. J Clin Lipidol. 2020. PMID: 32718857

3

Does apolipoprotein(a) heterogeneity influence lipoprotein(a) effects on fibrinolysis?

Hervio L, Chapman MJ, Thillet J, Loyau S, Anglés-Cano E. Hervio L, et al. Blood. 1993 Jul 15;82(2):392-7. Blood. 1993. PMID: 8329699 Free article.

4

Inhibition of fibrinolysis by lipoprotein(a).

Anglés-Cano E, de la Peña Díaz A, Loyau S. Anglés-Cano E, et al. Ann N Y Acad Sci. 2001;936:261-75. doi: 10.1111/j.1749-6632.2001.tb03514.x. Ann N Y Acad Sci. 2001. PMID: 11460483 Review.

5

Effects of lipoprotein(a) on the binding of plasminogen to fibrin and its activation by fibrin-bound tissue-type plasminogen activator.

Anglés-Cano E, Hervio L, Rouy D, Fournier C, Chapman JM, Laplaud M, Koschinsky ML. Anglés-Cano E, et al. Chem Phys Lipids. 1994 Jan;67-68:369-80. doi: 10.1016/0009-3084(94)90159-7. Chem Phys Lipids. 1994. PMID: 8187237

6

Lipoprotein(a) isoforms display differences in affinity for plasminogen-like binding to human mononuclear cells.

Kang C, Durlach V, Soulat T, Fournier C, Anglés-Cano E. Kang C, et al. Arterioscler Thromb Vasc Biol. 1997 Oct;17(10):2036-43. doi: 10.1161/01.atv.17.10.2036. Arterioscler Thromb Vasc Biol. 1997. PMID: 9351369

7

[Lipoprotein (a) :NSFA consensus].

Durlach V, Anglés-Cano E. Durlach V, et al. Among authors: angles cano e. Rev Prat. 2022 Feb;72(2):123-129. Rev Prat. 2022. PMID: 35289517 French.

8

The antifibrinolytic effect of lipoprotein(a) in heterozygous subjects is modulated by the relative concentration of each of the apolipoprotein(a) isoforms and their affinity for fibrin.

Hervio L, Girard-Globa A, Durlach V, Anglés-Cano E. Hervio L, et al. Eur J Clin Invest. 1996 May;26(5):411-7. doi: 10.1046/j.1365-2362.1996.156288.x. Eur J Clin Invest. 1996. PMID: 8796369 Clinical Trial.

9

Overview on fibrinolysis: plasminogen activation pathways on fibrin and cell surfaces.

Anglés-Cano E. Anglés-Cano E. Chem Phys Lipids. 1994 Jan;67-68:353-62. doi: 10.1016/0009-3084(94)90157-0. Chem Phys Lipids. 1994. PMID: 8187235 Review.

10

Evidence that modifications of Lp(a) in vivo inhibit plasmin formation on fibrin--a study with individual plasmas presenting natural variations of Lp(a).

Soulat T, Loyau S, Baudouin V, Durlach V, Gillery P, Garnotel R, Loirat C, Anglés-Cano E. Soulat T, et al. Thromb Haemost. 1999 Jul;82(1):121-7. Thromb Haemost. 1999. PMID: 10456465

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

145 results

Search Page